Scholarlink

<p><i>Pseudomonas aeruginosa</i> is a Gram-negative bacterium and a major opportunistic pathogen that can cause extensive acute and chronic infections. β-lactam antibiotics are the most commonly used prescription antibiotics worldwide and play a crucial role in the treatment of <i>Pseudomonas aeruginosa</i> infections. However, antibiotic resistance (AMR) is a global challenge. The β-lactam resistance in Gram-negative bacteria is due to the production of β-lactamases, including extended-spectrum β-lactamases, metallo-β-lactamases, and carbapenem-hydrolyzing class D β-lactamases. To restore the efficacy of this type of antibiotic, the most effective strategy is to combine it with β-lactamase inhibitors (BLI). In this study, we were pleasantly surprised to find that the quorum sensing inhibitor 2-(4-bromophenyl)-N-(2-oxotetrapyridinefuran-3-yl) butanamide (compound No.10) of <i>Pseudomonas aeruginosa</i>, when combined with β -lactam antibiotics, not only could inhibit the formation of biofilms in the standard and clinical strains of <i>Pseudomonas aeruginosa</i>, but also promoted the entry of antibiotics into the bacteria to exert their bactericidal effects. Moreover, it can also inhibit the expression of the drug resistance gene <i>ampc</i> in <i>Pseudomonas aeruginosa</i>, thereby suppressing the degradation effect of β-lactamase on β-lactam antibiotics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

N-acyl homoserine lactone quorum-sensing inhibitor acts as an antibiotic adjuvant to increase the susceptibility of Pseudomonas aeruginosa against β-lactam antibiotics

  • 期刊论文

  • 发表日期：

    2025年9月19日

查看全文
  • Juanyan Liu,
  • Zhenyu Wei,
  • Xinran Wang,
  • Yi Deng,
  • Haijuan Zhang,
  • Kailong Guan,
  • Xin Wang,
  • Hongyu Li,
  • Yang Li

摘要

Pseudomonas aeruginosa is a Gram-negative bacterium and a major opportunistic pathogen that can cause extensive acute and chronic infections. β-lactam antibiotics are the most commonly used prescription antibiotics worldwide and play a crucial role in the treatment of Pseudomonas aeruginosa infections. However, antibiotic resistance (AMR) is a global challenge. The β-lactam resistance in Gram-negative bacteria is due to the production of β-lactamases, including extended-spectrum β-lactamases, metallo-β-lactamases, and carbapenem-hydrolyzing class D β-lactamases. To restore the efficacy of this type of antibiotic, the most effective strategy is to combine it with β-lactamase inhibitors (BLI). In this study, we were pleasantly surprised to find that the quorum sensing inhibitor 2-(4-bromophenyl)-N-(2-oxotetrapyridinefuran-3-yl) butanamide (compound No.10) of Pseudomonas aeruginosa, when combined with β -lactam antibiotics, not only could inhibit the formation of biofilms in the standard and clinical strains of Pseudomonas aeruginosa, but also promoted the entry of antibiotics into the bacteria to exert their bactericidal effects. Moreover, it can also inhibit the expression of the drug resistance gene ampc in Pseudomonas aeruginosa, thereby suppressing the degradation effect of β-lactamase on β-lactam antibiotics.